These tumors were identified to be clinically distinct from NKTCL, with low genomic instability, upregulation of NK-κB, IFNγ, IL6-JAK-STAT3, and downregulation of EBV miRNA. This evidence concerns the gene STAT3 and extranodal nasal NK/T cell lymphoma.